Itb-Med

Itb-Med company information, Employees & Contact Information

Explore related pages

Related company profiles:

ITB-MED is developing the proprietary antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab), for several indications. ITB-MED is wholly committed to advancing and exploring the potential of TCD601, with a particular focus on its applications in transplantation and autoimmunity. The efforts extend to comprehensive worldwide clinical trials. ITB-MED is actively investigating further preclinical therapies to expand the reach of its novel immune-modulating approaches.

Company Details

Employees
47
Founded
-
Address
110 E 59th St, 28,sweden
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
New York
Looking for a particular Itb-Med employee's phone or email?

Itb-Med Questions

News

Sickle Cell Disease Market to Witness Promising Upswing by 2034, DelveInsight Forecasts | Sanofi, CSL Behring, ITB-Med LLC, Novo Nordisk A/S, Fortrea, Inc., Novartis, Afimmune, Pfizer, ADDMEDICA SASA - Barchart.com

Sickle Cell Disease Market to Witness Promising Upswing by 2034, DelveInsight Forecasts | Sanofi, CSL Behring, ITB-Med LLC, Novo Nordisk A/S, Fortrea, Inc., Novartis, Afimmune, Pfizer, ADDMEDICA SASA Barchart.com

First Gene-Edited Pig Kidney Functioned Until Recipient's Death - MedPage Today

First Gene-Edited Pig Kidney Functioned Until Recipient's Death MedPage Today

Cardiac allograft tolerance can be achieved in nonhuman primates by donor bone marrow and kidney cotransplantation - Science | AAAS

Cardiac allograft tolerance can be achieved in nonhuman primates by donor bone marrow and kidney cotransplantation Science | AAAS

Buoyed by long-term organ transplant data, ITBMed bags $67M to advance ex-MedImmune asset - Fierce Biotech

Buoyed by long-term organ transplant data, ITBMed bags $67M to advance ex-MedImmune asset Fierce Biotech

Archived procurement notices - Stop TB Partnership

Archived procurement notices Stop TB Partnership

Studies Reveal Cell-by-Cell Changes Caused When Pig Hearts & Kidneys Are Transplanted into Humans - NYU Langone Health

Studies Reveal Cell-by-Cell Changes Caused When Pig Hearts & Kidneys Are Transplanted into Humans NYU Langone Health

The 10 fastest-growing techbio startups in Europe - Sifted

The 10 fastest-growing techbio startups in Europe Sifted

ITBMed Completes up to $67M Equity Investment - FinSMEs

ITBMed Completes up to $67M Equity Investment FinSMEs

4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight - The Tech Portal

4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight The Tech Portal

Top Itb-Med Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant